A Securities and Exchange Commission investigation found that consultant Hoau-Yan Wang, PhD, an associate professor at the City University of New York, manipulated the clinical trial data using unblinded information, creating a false impression of significant improvements in biomarkers related to Alzheimer’s.
In addition to financial penalties, Mr. Barber and Dr. Burns agreed to bars of three and five years, respectively, from serving as officers or directors. The settlements are pending court approval, and Dr. Wang faces a $50,000 penalty for his role.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
